GlobeImmune (United States)
GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for GlobeImmune (United States), United States, covering academic research published from 2002 to 2020. Read More.
Open Access Percentage
48%
Total
Publications
54
Total Open
Publications
26
Total
Citations
3.2K
Open Access
Percentage
48%
Total
Publications
54
Total Open
Publications
26
Total
Citations
3.2K
Breakdown
Publisher Open
11%
Both
20%
Other Platform Open
17%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
4
Hybrid 12%
2
No Guarantees 65%
11
Other Platform Open
Domain 90%
18
Public 20%
4
Other Internet 10%
2
Institution 5%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 18 |
Europe PMC | Domain | 14 |
Figshare | Public | 4 |
Semantic Scholar | Public | 2 |
unimore.it OAI-PMH Repository | Institution | 1 |
DOI | Other Internet | 1 |
CiteSeer X | Other Internet | 1 |